Antibe Therapeutics Inc. (ATBPF)
USD 0.22
(0.0%)
USD 0.22
(0.0%)
| Year | Net Debt | Net Debt Growth |
|---|---|---|
| 2023 | -6.75 Million CAD | 80.59% |
| 2022 | -34.8 Million CAD | 51.48% |
| 2021 | -71.73 Million CAD | -1795.75% |
| 2020 | -3.78 Million CAD | 3.48% |
| 2019 | -3.92 Million CAD | -79.15% |
| 2018 | -2.18 Million CAD | -195.9% |
| 2017 | 2.28 Million CAD | -30.52% |
| 2016 | 3.28 Million CAD | 927.13% |
| 2015 | -397.08 Thousand CAD | 89.42% |
| 2014 | -3.75 Million CAD | -761.56% |
| 2013 | 567.57 Thousand CAD | 707.77% |
| 2012 | -93.38 Thousand CAD | 0.0% |
| Year | Net Debt | Net Debt Growth |
|---|---|---|
| 2024 Q1 | -8.79 Million CAD | -30.17% |
| 2024 Q3 | -11.33 Million CAD | -173.69% |
| 2024 Q2 | -4.14 Million CAD | 52.88% |
| 2023 Q2 | -13.6 Million CAD | 26.65% |
| 2023 Q3 | -10.52 Million CAD | 22.6% |
| 2023 FY | -6.75 Million CAD | 80.59% |
| 2023 Q4 | -6.75 Million CAD | 35.84% |
| 2023 Q1 | -18.54 Million CAD | 46.72% |
| 2022 Q4 | -34.8 Million CAD | 40.59% |
| 2022 Q3 | -58.59 Million CAD | 3.13% |
| 2022 FY | -34.8 Million CAD | 51.48% |
| 2022 Q2 | -60.48 Million CAD | 9.17% |
| 2022 Q1 | -66.58 Million CAD | 7.18% |
| 2021 Q2 | -22.35 Million CAD | 26.96% |
| 2021 Q4 | -71.73 Million CAD | -374.06% |
| 2021 FY | -71.73 Million CAD | -1795.75% |
| 2021 Q1 | -30.6 Million CAD | -708.67% |
| 2021 Q3 | -15.13 Million CAD | 32.3% |
| 2020 Q1 | -1.53 Million CAD | 60.8% |
| 2020 FY | -3.78 Million CAD | 3.48% |
| 2020 Q4 | -3.78 Million CAD | 9.41% |
| 2020 Q3 | -4.17 Million CAD | 29.01% |
| 2020 Q2 | -5.88 Million CAD | -282.82% |
| 2019 Q4 | -3.92 Million CAD | -210.18% |
| 2019 Q1 | -2.27 Million CAD | -3.74% |
| 2019 Q3 | -1.26 Million CAD | -10.79% |
| 2019 FY | -3.92 Million CAD | -79.15% |
| 2019 Q2 | -1.14 Million CAD | 49.75% |
| 2018 Q3 | 2.84 Million CAD | 51.16% |
| 2018 FY | -2.18 Million CAD | -195.9% |
| 2018 Q2 | 1.88 Million CAD | 497.82% |
| 2018 Q4 | -2.18 Million CAD | -176.81% |
| 2018 Q1 | 315.28 Thousand CAD | -86.18% |
| 2017 FY | 2.28 Million CAD | -30.52% |
| 2017 Q3 | 1.93 Million CAD | -45.98% |
| 2017 Q4 | 2.28 Million CAD | 17.99% |
| 2017 Q1 | 2.43 Million CAD | -25.9% |
| 2017 Q2 | 3.58 Million CAD | 47.12% |
| 2016 Q3 | 2.2 Million CAD | 567.28% |
| 2016 Q4 | 3.28 Million CAD | 48.9% |
| 2016 Q2 | -472.03 Thousand CAD | 60.4% |
| 2016 Q1 | -1.19 Million CAD | -200.17% |
| 2016 FY | 3.28 Million CAD | 927.13% |
| 2015 FY | -397.08 Thousand CAD | 89.42% |
| 2015 Q3 | -906.19 Thousand CAD | 54.57% |
| 2015 Q2 | -1.99 Million CAD | 37.42% |
| 2015 Q1 | -3.18 Million CAD | 15.11% |
| 2015 Q4 | -397.08 Thousand CAD | 56.18% |
| 2014 Q2 | -1.47 Million CAD | 12.83% |
| 2014 Q4 | -3.75 Million CAD | -150.42% |
| 2014 Q3 | -1.49 Million CAD | -1.99% |
| 2014 FY | -3.75 Million CAD | -761.56% |
| 2014 Q1 | -1.68 Million CAD | -397.16% |
| 2013 FY | 567.57 Thousand CAD | 707.77% |
| 2013 Q4 | 567.57 Thousand CAD | 0.0% |
| 2012 FY | -93.38 Thousand CAD | 0.0% |
| Name | Net Debt | Net Debt Difference |
|---|---|---|
| IR-Med Inc. | -606 Thousand USD | -1014.686% |
| CVR Medical Corp. | - USD | Infinity% |
| BioElectronics Corporation | 14.82 Million USD | 145.56% |
| Medical Supply International USA, Inc. | 216.6 Thousand USD | 3218.537% |
| Polarean Imaging plc | -5.94 Million USD | -13.596% |
| Avitar, Inc. | 5.17 Million USD | 230.628% |
| AVITA Medical, Inc. | -26.23 Million USD | 74.249% |
| Manhattan Scientifics, Inc. | -7000.00 USD | -96400.0% |
| Össur hf. | 395.08 Million USD | 101.71% |
| Zecotek Photonics Inc. | 2.76 Million USD | 344.529% |
| QHSLab, Inc. | 1.72 Million USD | 490.469% |
| Wellstar International, Inc. | 51.36 Million USD | 113.15% |
| Össur hf. | 395.08 Million USD | 101.71% |
| Bionovate Technologies Corp | - USD | Infinity% |
| EKF Diagnostics Holdings plc | -4.61 Million USD | -46.302% |
| Escalon Medical Corp. | 315.68 Thousand USD | 2239.784% |
| Aurora Spine Corporation | 1.9 Million USD | 454.1% |
| BrainsWay Ltd. | -10.32 Million USD | 34.545% |
| Lattice Biologics Ltd. | - USD | Infinity% |
| NewCardio, Inc. | 2.41 Million USD | 379.707% |
| Hamilton Thorne Ltd. | 18.12 Million USD | 137.267% |
| Vivos Inc. | -1.59 Million USD | -324.233% |
| MicroPort Scientific Corporation | 673.58 Million USD | 101.003% |
| Kelyniam Global, Inc. | 487.33 Thousand USD | 1486.116% |
| REMSleep Holdings, Inc. | -540.98 Thousand USD | -1148.646% |
| CYduct Diagnostics, Inc. | 640.19 Thousand USD | 1155.144% |
| Nanomix Corporation | 11.38 Million USD | 159.311% |
| Theraclion SA | -5.86 Million EUR | -15.184% |
| Lifeline Biotechnologies, Inc. | - USD | Infinity% |
| Wellness Center USA, Inc. | 3.98 Million USD | 269.49% |
| Positron Corporation | 1.68 Million USD | 500.443% |
| Rafina Innovations Inc. | - USD | Infinity% |
| Electromedical Technologies, Inc. | 1.61 Million USD | 519.346% |
| Lombard Medical, Inc. | 11.49 Million USD | 158.765% |
| ALR Technologies Inc. | 19.14 Million USD | 135.277% |
| Stratec SE | 119.12 Million USD | 105.671% |
| Vycor Medical, Inc. | 1.05 Million USD | 741.527% |
| Heart Tronics, Inc. | 54.99 Thousand USD | 12382.935% |
| Nu-Med Plus, Inc. | 93.19 Thousand USD | 7348.321% |
| Perimeter Medical Imaging AI, Inc. | -13.78 Million USD | 51.006% |
| SANUWAVE Health, Inc. | 30.14 Million USD | 122.407% |
| VMS Rehab Systems, Inc. | 133.52 USD | 5059267.166% |
| Guided Therapeutics, Inc. | 1.46 Million USD | 560.464% |
| Ingen Technologies, Inc. | 630.91 Thousand USD | 1170.66% |
| Odyssey Group International, Inc. | 2.1 Million USD | 420.477% |
| United American Healthcare Corporation | -9.32 Million USD | 27.576% |
| ECGI Holdings, Inc. | 3.17 Million USD | 313.008% |
| Capital Group Holdings, Inc. | -3508.00 USD | -192459.863% |
| ADM Tronics Unlimited, Inc. | 262.61 Thousand USD | 2672.177% |
| Urologix, Inc. | 4.61 Million USD | 246.371% |
| Rapid Therapeutic Science Laboratories, Inc. | 4.2 Million USD | 260.473% |
| Nexeon MedSystems Inc. | 3.33 Million USD | 302.777% |
| SS Innovations International, Inc. | 1.18 Million USD | 669.876% |
| Qualis Innovations, Inc. | 6671.00 USD | 101359.182% |
| Smith & Nephew plc | 2.77 Billion USD | 100.243% |
| NIOX Group Plc | -23.93 Million USD | 71.775% |
| Fuse Medical, Inc. | 1.75 Million USD | 484.792% |
| Broncus Holding Corporation | -81.42 Million USD | 91.704% |
| Brain Scientific Inc. | 2.11 Million USD | 419.269% |
| Pressure BioSciences, Inc. | 22.67 Million USD | 129.788% |
| Health Logic Interactive Inc. | 39.55 Thousand USD | 17176.624% |